Journal article 1092 views 197 downloads
Constructing ‘exceptionality’: a neglected aspect of NHS rationing
David Hughes,
Shane Doheny
Sociology of Health and Illness, Volume: 41, Issue: 8, Pages: 1600 - 1617
Swansea University Author: David Hughes
-
PDF | Accepted Manuscript
Download (357.59KB)
DOI (Published version): 10.1111/1467-9566.12976
Abstract
The principle of exceptionality involves assessing whether a patient is sufficiently different from the generality of patients to justify providing a treatment, such as an expensive cancer drug, not approved for routine funding. In England, individual requests for certain high-cost treatments are co...
Published in: | Sociology of Health and Illness |
---|---|
ISSN: | 0141-9889 1467-9566 |
Published: |
Wiley
2019
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa50556 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2019-06-05T11:07:48Z |
---|---|
last_indexed |
2020-10-20T03:00:59Z |
id |
cronfa50556 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2020-10-19T13:13:35.5241323</datestamp><bib-version>v2</bib-version><id>50556</id><entry>2019-05-29</entry><title>Constructing ‘exceptionality’: a neglected aspect of NHS rationing</title><swanseaauthors><author><sid>f1fbd458e3c75d8b597c0ac8036f2b88</sid><firstname>David</firstname><surname>Hughes</surname><name>David Hughes</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2019-05-29</date><deptcode>FGMHL</deptcode><abstract>The principle of exceptionality involves assessing whether a patient is sufficiently different from the generality of patients to justify providing a treatment, such as an expensive cancer drug, not approved for routine funding. In England, individual requests for certain high-cost treatments are considered by funding request panels that examine exceptionality alongside treatment efficacy and cost as the main criteria for funding. This was also the case in Wales until September 2017. Our paper draws on audio recordings of panel meetings and interviews in a Welsh Health Board to investigate how exceptionality was constructed in discussions. It focuses on the combination of different decision criteria in meeting talk, particularly regarding the discourses associated with efficacy and exceptionality. Exceptionality is a malleable category that raised questions about the evidence-based nature of panel decision making. For example, the paper discusses the use of subgroup data from trials and the difficulty of deciding how small a subgroup of patients should be before it is deemed exceptional. Determining exceptionality has been a key mechanism for deciding that a minority of NHS patients can still receive high-cost treatments not routinely provided for all. As a neglected rationing mechanism.</abstract><type>Journal Article</type><journal>Sociology of Health and Illness</journal><volume>41</volume><journalNumber>8</journalNumber><paginationStart>1600</paginationStart><paginationEnd>1617</paginationEnd><publisher>Wiley</publisher><issnPrint>0141-9889</issnPrint><issnElectronic>1467-9566</issnElectronic><keywords>rationing; individual patient funding requests; evidence-based medicine; exceptionality; clinical effectiveness</keywords><publishedDay>1</publishedDay><publishedMonth>11</publishedMonth><publishedYear>2019</publishedYear><publishedDate>2019-11-01</publishedDate><doi>10.1111/1467-9566.12976</doi><url>http://dx.doi.org/10.1111/1467-9566.12976</url><notes/><college>COLLEGE NANME</college><department>Medicine, Health and Life Science - Faculty</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>FGMHL</DepartmentCode><institution>Swansea University</institution><degreesponsorsfunders>NIHR</degreesponsorsfunders><apcterm/><lastEdited>2020-10-19T13:13:35.5241323</lastEdited><Created>2019-05-29T09:40:53.3855230</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">School of Health and Social Care - Public Health</level></path><authors><author><firstname>David</firstname><surname>Hughes</surname><order>1</order></author><author><firstname>Shane</firstname><surname>Doheny</surname><order>2</order></author></authors><documents><document><filename>0050556-10072019151921.pdf</filename><originalFilename>50556.pdf</originalFilename><uploaded>2019-07-10T15:19:21.3800000</uploaded><type>Output</type><contentLength>334583</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2020-06-20T00:00:00.0000000</embargoDate><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807> |
spelling |
2020-10-19T13:13:35.5241323 v2 50556 2019-05-29 Constructing ‘exceptionality’: a neglected aspect of NHS rationing f1fbd458e3c75d8b597c0ac8036f2b88 David Hughes David Hughes true false 2019-05-29 FGMHL The principle of exceptionality involves assessing whether a patient is sufficiently different from the generality of patients to justify providing a treatment, such as an expensive cancer drug, not approved for routine funding. In England, individual requests for certain high-cost treatments are considered by funding request panels that examine exceptionality alongside treatment efficacy and cost as the main criteria for funding. This was also the case in Wales until September 2017. Our paper draws on audio recordings of panel meetings and interviews in a Welsh Health Board to investigate how exceptionality was constructed in discussions. It focuses on the combination of different decision criteria in meeting talk, particularly regarding the discourses associated with efficacy and exceptionality. Exceptionality is a malleable category that raised questions about the evidence-based nature of panel decision making. For example, the paper discusses the use of subgroup data from trials and the difficulty of deciding how small a subgroup of patients should be before it is deemed exceptional. Determining exceptionality has been a key mechanism for deciding that a minority of NHS patients can still receive high-cost treatments not routinely provided for all. As a neglected rationing mechanism. Journal Article Sociology of Health and Illness 41 8 1600 1617 Wiley 0141-9889 1467-9566 rationing; individual patient funding requests; evidence-based medicine; exceptionality; clinical effectiveness 1 11 2019 2019-11-01 10.1111/1467-9566.12976 http://dx.doi.org/10.1111/1467-9566.12976 COLLEGE NANME Medicine, Health and Life Science - Faculty COLLEGE CODE FGMHL Swansea University NIHR 2020-10-19T13:13:35.5241323 2019-05-29T09:40:53.3855230 Faculty of Medicine, Health and Life Sciences School of Health and Social Care - Public Health David Hughes 1 Shane Doheny 2 0050556-10072019151921.pdf 50556.pdf 2019-07-10T15:19:21.3800000 Output 334583 application/pdf Accepted Manuscript true 2020-06-20T00:00:00.0000000 true eng |
title |
Constructing ‘exceptionality’: a neglected aspect of NHS rationing |
spellingShingle |
Constructing ‘exceptionality’: a neglected aspect of NHS rationing David Hughes |
title_short |
Constructing ‘exceptionality’: a neglected aspect of NHS rationing |
title_full |
Constructing ‘exceptionality’: a neglected aspect of NHS rationing |
title_fullStr |
Constructing ‘exceptionality’: a neglected aspect of NHS rationing |
title_full_unstemmed |
Constructing ‘exceptionality’: a neglected aspect of NHS rationing |
title_sort |
Constructing ‘exceptionality’: a neglected aspect of NHS rationing |
author_id_str_mv |
f1fbd458e3c75d8b597c0ac8036f2b88 |
author_id_fullname_str_mv |
f1fbd458e3c75d8b597c0ac8036f2b88_***_David Hughes |
author |
David Hughes |
author2 |
David Hughes Shane Doheny |
format |
Journal article |
container_title |
Sociology of Health and Illness |
container_volume |
41 |
container_issue |
8 |
container_start_page |
1600 |
publishDate |
2019 |
institution |
Swansea University |
issn |
0141-9889 1467-9566 |
doi_str_mv |
10.1111/1467-9566.12976 |
publisher |
Wiley |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
School of Health and Social Care - Public Health{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}School of Health and Social Care - Public Health |
url |
http://dx.doi.org/10.1111/1467-9566.12976 |
document_store_str |
1 |
active_str |
0 |
description |
The principle of exceptionality involves assessing whether a patient is sufficiently different from the generality of patients to justify providing a treatment, such as an expensive cancer drug, not approved for routine funding. In England, individual requests for certain high-cost treatments are considered by funding request panels that examine exceptionality alongside treatment efficacy and cost as the main criteria for funding. This was also the case in Wales until September 2017. Our paper draws on audio recordings of panel meetings and interviews in a Welsh Health Board to investigate how exceptionality was constructed in discussions. It focuses on the combination of different decision criteria in meeting talk, particularly regarding the discourses associated with efficacy and exceptionality. Exceptionality is a malleable category that raised questions about the evidence-based nature of panel decision making. For example, the paper discusses the use of subgroup data from trials and the difficulty of deciding how small a subgroup of patients should be before it is deemed exceptional. Determining exceptionality has been a key mechanism for deciding that a minority of NHS patients can still receive high-cost treatments not routinely provided for all. As a neglected rationing mechanism. |
published_date |
2019-11-01T04:02:03Z |
_version_ |
1763753195563122688 |
score |
11.03559 |